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PPRECLINICAL STUDY
An Elastic, Biodegradable Cardiac Patch Induces
Contractile Smooth Muscle and Improves Cardiac
Remodeling and Function in Subacute Myocardial Infarction
Kazuro L. Fujimoto, MD,*† Kimimasa Tobita, MD,†‡§ W. David Merryman, PHD,§
Jianjun Guan, PHD,*† Nobuo Momoi, MD, PHD,‡ Donna B. Stolz, PHD, Michael S. Sacks, PHD,†§
Bradley B. Keller, MD,†‡ William R. Wagner, PHD*†§
Pittsburgh, Pennsylvania
Objectives Our objective in this study was to apply an elastic, biodegradable polyester urethane urea (PEUU) cardiac patch
onto subacute infarcts and to examine the resulting cardiac ventricular remodeling and performance.
Background Myocardial infarction induces loss of contractile mass and scar formation resulting in adverse left ventricular
(LV) remodeling and subsequent severe dysfunction.
Methods Lewis rats underwent proximal left coronary ligation. Two weeks after coronary ligation, a 6-mm diameter micro-
porous PEUU patch was implanted directly on the infarcted LV wall surface (PEUU patch group, n  14). Sham
surgery was performed as an infarction control (n  12). The LV contractile function, regional myocardial wall
compliance, and tissue histology were assessed 8 weeks after patch implantation.
Results The end-diastolic LV cavity area (EDA) did not change, and the fractional area change (FAC) increased in the
PEUU patch group (p  0.05 vs. week 0), while EDA increased and FAC decreased in the infarction control group
(p  0.05). The PEUU patch was largely resorbed 8 weeks after implantation and the LV wall was thicker than
infarction control (p  0.05 vs. control group). Abundant smooth muscle bundles with mature contractile pheno-
type were found in the infarcted myocardium of the PEUU group. The myocardial compliance of the PEUU group
was distributed between normal myocardium and infarction control (p  0.001).
Conclusions Implantation of a novel biodegradable PEUU patch onto a subacute myocardial infarction promoted contractile
phenotype smooth muscle tissue formation and improved cardiac remodeling and contractile function at the
chronic stage. Our findings suggest a new therapeutic option against post-infarct cardiac failure. (J Am Coll
Cardiol 2007;49:2292–300) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.02.050c
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sostinfarct left ventricular (LV) remodeling is a well-
escribed compensatory mechanism of congestive heart
ailure (CHF), characterized by progressive ventricular
hamber dilatation, wall thinning, and sphericity that allows
he failing ventricle to maintain cardiac output by increasing
troke volume. This compensatory mechanism in the long-
erm causes maladaptive changes in myocardial structural
nd function (1,2). Among clinical indicators, LV dilation
nd increased LV sphericity are sensitive predictors of poor
ong-term outcome and mortality (3). Therapeutic strate-
ies to antagonize LV remodeling, such as angiotensin-
rom the *Department of Surgery, †McGowan Institute for Regenerative Medicine,
Department of Pediatrics, Children’s Hospital of Pittsburgh, §Department of
ioengineering, and the Department of Cell Biology and Physiology, University of
ittsburgh, Pittsburgh, Pennsylvania. This work was supported by the National
eart, Lung, and Blood Institute, grant HL069368.D
Manuscript received October 23, 2006; revised manuscript received January 31,
007, accepted February 18, 2007.onverting enzyme inhibitors and/or beta-blockers, have
roven beneficial in treating CHF (4). Despite the value of
uch medical approaches, progression from myocardial in-
arction to CHF remains a tremendous burden in terms of
orbidity and mortality as well as financial cost.
Surgical approaches have been proposed that are based on
he concept of reducing the LV cavity volume to restore wall
ension toward normal levels, thus interrupting the remod-
ling process and improving hemodynamic status. Both the
ndoventricular circular patch plasty technique (the Dor
rocedure) (5,6) and partial left ventriculectomy (the Batista
rocedure) (7) have been clinically implemented. However,
hese therapies are restricted to patients with severe dilation
nd dysfunction many years after an infarction. Another
urgical approach that has been investigated is epicardial
estraint therapy, where a wrap is applied over the cardiac
urface from the apex upward. The Acorn Cardiac Support
evice (Acorn Cardiovascular, St. Paul, Minnesota), which
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June 12, 2007:2292–300 Biodegradable Patch Improves Cardiac Remodelings comprised of a polyester mesh (8), and the Paracor device
Paracor Medical, Inc., Sunnyvale, California), which uti-
izes a nitinol mesh (9), employ this strategy. These ap-
roaches both utilize nonbiodegradable materials and result
n a permanent foreign body encapsulating the epicardium.
ore recently, several groups have pursued tissue engineer-
ng approaches for ventricular wall reconstruction surgery
10–12), in contrast to the wide variety of cellular injection
pproaches currently under investigation (13). The feasibil-
ty of translating these latter approaches to the clinic remains
hallenging with concerns about cell sourcing and character-
zation, and the practicalities of in vitro patch development
eing of concern.
Given these observations, we hypothesized that an attrac-
ive approach to the management of LV dilation would be
o apply an elastic patch to the infarcted ventricle where the
atch was not a wrap, but might be sized to the infarct, and
here the patch was both highly elastic and biodegradable
o that the material would erode over several weeks. By
voiding cellular components, the approach might be more
eadily translatable to clinical investigations. Toward this
nd, we have designed and developed a porous, elastic
caffold from a biodegradable elastomer that can be pro-
essed into a variety of formats compatible with cardiovas-
ular placement (14,15). Our objective in this study was to
pply this scaffold as a cardiac patch onto subacute infarcts
hat had developed over a 2-week period after coronary
igation in the rat model and to examine the resulting
ardiac performance and ventricular remodeling. Our hy-
othesis was that placement of this patch would alter the
rogression of remodeling, which leads to ventricular wall
hinning and fibrosis, and would preserve contractile
unction.
ethods
xperimental animals. Adult female Lewis rats (Harlan
prague Dawley, Indianapolis, Indiana) weighing 200 g to
50 g were used. The protocol followed National Institutes
f Health guidelines for animal care and was approved by
he University of Pittsburgh’s Institutional Animal Care and
se Committee and Children’s Hospital of Pittsburgh
nimal Research Care Committee.
lastomeric biodegradable microporous polyester ure-
hane urea (PEUU) patch. The circular PEUU patch was
ade of a polyester urethane urea that was synthesized in
he investigators’ laboratory as previously described (14),
nd processed using thermally induced phase separation
echniques (15) into a patch with interconnected micropores
Fig. 1A). The patch possessed 91% porosity and a 91-m
verage pore size. Mechanically, the patch was elastic with a
ensile strength of 0.78 MPa and elongation at rupture of
57%. The material was sized to circular patches 6 mm in
iameter  300 m thick (Fig. 1B). The patches were
mmersed in 100% ethanol for 30 min, followed by immer- Rion in phosphate-buffered saline
nd exposure to the ultraviolet
ight source for 1 h before
mplantation.
roximal left coronary artery
igation. Animal anesthesia was
nduced by 3.0% isoflurane inhala-
ion followed by intubation and
onnection to a rodent volume-
ontrolled mechanical ventilator.
he heart was exposed through a
eft thoracotomy, monitoring elec-
rocardiogram, and tail cuff blood
ressure. The proximal left anterior
escending coronary artery was li-
ated with 7-0 polypropylene. Myo-
ardial ischemia was confirmed by
egional cyanosis and ST-segment
levation. The incision was closed in
ayers with 4-0 silk continuous
utures.
EUU patch implantation. Two
eeks after coronary artery liga-
ion, animals were anesthetized and examined echocardio-
raphically for infarct size as estimated by the percentage of
car area (akinetic or dyskinetic regions) to LV free wall area
11). A total of 26 rats with infarcts greater than 25% of the
V free wall were divided into 2 groups: PEUU patch repair
patch group; n  14) and sham repair (infarction control
roup; n  12). Through a left thoracotomy, the infarcted
nterior wall was exposed. Before affixing the patch, the
urface of the infarcted area (less than 0.1 mm thickness),
ncluding the remnant epicardium and some of the inte-
rated fibrous tissue, was scraped and removed at the patch
mplant site. Using 7-0 polypropylene with over-and-over
eripheral sutures, the anterior infarcted myocardium was
overed with a PEUU patch. For the infarction control
roup, a thoracotomy was performed 2 weeks after coronary
igation, but no scraping or patch placement was performed.
ix age-matched rats without coronary ligation or surgical
ntervention served as a control group.
istology. Eight weeks after patch implantation (10 weeks
fter myocardial infarction), rats in both surgical groups
ere anesthetized, and the heart was exposed and arrested
y apical injection of 2 ml of a hypothermic arresting
olution (68 mmol/l NaCl, 60 mmol/l KCl, 36 mmol/l
aHCO3, 2.0 mmol/l MgCl2, 1.4 mmol/l Na2SO4, 11
mol/l dextrose, 30 mmol/l butanedione monoxime,
0,000 U/l of heparin). The embedded frozen LV tissues
ere serially sectioned at 8 m in the LV transverse
irection. Hematoxylin and eosin staining and immunohis-
ochemical staining were performed as previously described
16) with antibodies against alpha-smooth muscle actin
SMA) (Sigma, St. Louis, Missouri), CD 31 (Serotec,
Abbreviations
and Acronyms
bFGF  basic fibroblast
growth factor
CHF  congestive heart
failure
EDA  end-diastolic left
ventricular cavity area
ESA  end-systolic left
ventricular cavity area
FAC  fractional area
change
LV  left ventricular
PEUU  polyester urethane
urea
P-E  pressure-strain
SMA  smooth muscle
actin
SMMHC-2  smooth muscle
myosin heavy chain 2
VEGF  vascular
endothelial growth factoraleigh, North Carolina), caldesmon (Abcam, Cambridge,
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Biodegradable Patch Improves Cardiac Remodeling June 12, 2007:2292–300assachusetts), calponin (Abcam), smooth muscle myosin
eavy chain 2 (SMMHC-2, Abcam), SM-22 (Abcam),
asic fibroblast growth factor (bFGF, Serotec), or vascular
ndothelial growth factor (VEGF, Santa Cruz Biotechnol-
gy, Santa Cruz, California). Nuclei were stained with
=,6-Diamidino-2-phenyindole (DAPI, Sigma). To observe
he pattern of -SMA–positive staining across the infarcted
all, 5 to 7 fields at 100 were digitally photographed for
ach heart and composite images assembled (NIH image
nd Adobe Photoshop, San Jose, California) (n  5
ats/group).
V wall thickness and capillary density. For each LV
ample, 5 different microscopic fields at 100 for the wall
hickness measurement and 10 different fields at 200 for
apillary density were photographed for each rat. The wall
hickness of the infarcted anterior wall (patch implanted
egion) was analyzed using NIH Image software for patch
nd infarction control groups (n 5 rats/group). Capillaries
ere recognized as tubular structures positively stained for
Figure 1 Features of PEUU and Representative Images, at 8 W
Electron micrograph of the polyester urethane urea (PEUU) material (A). Polyester
tive images, 8 weeks after implantation, of the anterior view of infarction control (
E and F, respectively. Black arrows point to the implanted PEUU patch, and white
mm in C to F. P  the patch implanted area; S  the infarcted scar.D31 as previously described (16). transmission electron microscopy. Two hearts from each
roup were processed and imaged with transmission elec-
ron microscopy as previously described (17). Thin sections
80 nm) were examined with JEOL 1210 TEM system
JEOL USA, Peabody, Massachusetts). Digital images
ere obtained using a side-mount AMT 2k digital
amera (Advanced Microscopy Technologies, Danvers,
assachusetts).
chocardiography. Echocardiography was performed at
he time of patch implantation (0 weeks, 2 weeks postin-
arction), 4 and 8 weeks after patch implantation. The same
ime points were measured for all groups. Rats were anes-
hetized with isoflurane inhalation. Standard transthoracic
chocardiography was performed using the Acuson Sequoia
256 system with 13-MHz linear ultrasonic transducer
15L8; Acuson Corporation, Mountain View, California) in
phased-array format. B-mode measurements on the LV
hort-axis view (papillary muscle level) were performed (16).
he end-diastolic (EDA) and end-systolic (ESA) LV in-
After Implantation
ne urea patch in final format (6-mm diameter  300 m thick) (B). Representa-
PEUU patched (D) hearts. The cross-sectional view of both groups is shown in
s indicate the infarcted anterior wall. Scale bar: 500 m in A, 1 mm in B, 55eeks
uretha
C) and
arrowernal cavity areas were measured by tracing the endocardial
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June 12, 2007:2292–300 Biodegradable Patch Improves Cardiac Remodelingorder. The regional EDA and ESA at the infarcted
ntero-lateral wall segment were also measured using a
oating centroid method (18). The global and regional LV
ractional area change (%FAC) were estimated as %FAC 
(LVEDA  LVESA)  LVEDA]  100%. All measure-
ents were performed using Scion Image software (Scion
mage, Fredrick, Maryland).
egional myocardial compliance. Passive LV inflation
as performed to quantify regional myocardial compliance
n the infarction zone (19). Coronary circulation was per-
used through an aortic cannula with arresting solution.
fter perfusion, coronary arteries were occluded at the
oronary ostium, and mitral leaflets were completely closed
y 7-0 polypropylene suture. For LV surface strain mea-
urements, 4 small graphite particles were placed 4 mm
part in a square configuration on the center of infarcted LV
picardial surface with butyl-cyanoacrylate glue. The heart
as submerged in a chamber containing arresting solution
hat allowed entrance of a boroscope coupled to a CCD
amera for imaging. As the infarcted region was sufficiently
mall (6-mm diameter), dual-camera, stereo imaging of the
urved surface was unnecessary. Markers were tracked
ontinuously using a customized LabVIEW (National In-
truments, Austin, Texas) program.
Ventricular pressure was applied with a volume-infusion
ump (model sp210w, World Precision Instruments, Sara-
ota, Florida) that formed a continuous connection with the
ured cannula and a 2-F micromanometer-tipped catheter
model SPR631, Millar Instruments, Houston, Texas).
uring infusion, real-time strains in both directions (cir-
umferential, E11 and longitudinal, E22) were computed
rom 2-dimensional marker displacements using previous
ethods (20), and the applied pressure was simultaneously
ecorded. The inflation test was performed sequentially 3
imes in each sample by infusing arresting solution to a
aximum pressure of 30 mm Hg, confirming that inflation/
eflation volumes were reproducible for all cycles. Pressure-
train (P-E) relations were determined for all groups (n  4
ats/group).
tatistics. All data are expressed as mean  standard
eviation. Analyses utilized SPSS software (SPSS Inc.,
hicago, Illinois). The wall thickness in each group was
ompared by Student t test. Echocardiography data and
-E analyses were compared by 2-way repeated analysis of
ariance with Tukey’s test. Statistical significance was de-
ned at a value of p  0.05.
esults
xternal morphology. There were no early or late postop-
rative deaths in either surgical group. After an 8-week
mplantation period, the PEUU patch material was found to
ave formed no strong adhesions with the chest wall, and its
urface was covered with connective tissue (Figs. 1C and
F). In examining the heart in transverse cross section, it
as consistently found that the patch was well merged with ihe cardiac tissue and restored the LV wall thickness in the
nfarction region relative to hearts from the infarction
ontrol group.
istology. In examining histological sections stained with
ematoxylin and eosin, it was seen that the majority of the
EUU patch was absorbed and the remnant area of the
atch appeared to be infiltrated with macrophages and
broblasts. The ventricular walls to which PEUU patches
ere applied were thicker and contained more dense and
uscle-like bundles than the infarction control (Figs. 2A
nd 2B). The muscle-like bundles were found under the
atch regions stained positively for -SMA (Figs. 2C to
F). Reviewing -SMA expression across the infarct region
rom 5 random samples in each experimental group dem-
nstrated that in the infarction control group, -SMA was
poradically expressed and primarily associated with vascular
tructures in all samples. In contrast, for the PEUU patch
roup, there were 2 patterns of -SMA staining: a uniform
istribution of -SMA–positive tissue beneath the whole
atch area, or clustered regions of -SMA–positive tissue.
urther immunohistochemical staining demonstrated
hat caldesmon, calponin, SM 22, and SMMHC-2
Fig. 3A), proteins that are associated with contractile
unction, co-localized with -SMA–positive cells. Electron
icrographs of the muscle-like bundles demonstrated that
he aligned cells were rich in myofibrils and clustered
itochondria typical of smooth muscle cell ultrastructure.
umerous caveolae along the membrane and dense bodies
ithin the cytoplasm were observed, strongly suggesting a
mooth muscle phenotype (Figs. 3B to 3D).
all thickness and capillary density. From histological
ection analysis, the LV myocardial wall for the PEUU
mplantation group was found to be thicker than that in the
nfarction control group (985  90 m vs. 480  62 m,
 0.01). The capillary density of the PEUU patch group was
ignificantly increased compared with that in the infarction
ontrol group (275  56/mm2 vs. 102  17/mm2, p  0.05).
rowth factor expression. Basic fibroblast growth factor
nd VEGF immunohistochemical staining (Figs. 4A to 4D)
emonstrated expression of both growth factors around the
apillaries and smooth muscle bundles in the PEUU patch
roup, whereas in the infarction control group, staining for
oth growth factors was sparse and appeared to be associ-
ted with vascular structures.
V cavity size and contractile function. A significant
nteraction was found to exist between the experimental
roups and observed time points (p 0.001). At the time of
EUU patch implantation (0 weeks), the LV EDA was
ignificantly larger, and the %FAC was significantly smaller
han for the age-matched normal control animals, confirm-
ng post-infarction LV dilation and dysfunction. The patch
roup did not experience a change in EDA after patch
mplantation at any of the time points, while at 8 weeks, the
DA of the infarction control group was significantly
ncreased versus the 0 week point (Fig. 5). The EDA of the
nfarction control group at 8 weeks was also significantly
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Biodegradable Patch Improves Cardiac Remodeling June 12, 2007:2292–300arger than that of the patch group. The %FAC was
ncreased in the patch group at 8 weeks relative to the time
f patch implantation, while for the infarction control group
he %FAC had significantly decreased by 8 weeks. The
egional %FAC in the PEUU patch group at 8 weeks was
ignificantly larger than that in the infarction control group
27  9.0% vs. 15  10%), which was similar to the global
FAC. It was noted that negative values of %FAC (dyski-
etic) were obtained for 2 samples of the infarction control
roup, an effect not observed in the PEUU patch group.
egional LV myocardial compliance. Both circumferen-
ial and longitudinal LV myocardial P-E curves (Fig. 6)
evealed that at 8 weeks the LV wall had stiffened in the
nfarction control group and exhibited the least compliance.
ressure-strain curves for the PEUU patch group fell
etween the normal and infarction groups in the circumfer-
ntial direction (p  0.001) and in the longitudinal direc-
ion followed essentially the same path as the normal group.
iscussion
ur results demonstrated that implantation of an elastic,
iodegradable PEUU patch onto the ventricular region of a
ubacute myocardial infarct in the rat model preserved LV
eometry and improved contractile function relative to that
n nontreated animals. This effect occurred even though the
atch was placed 2 weeks after the time of LV infarction.
uring this clinically relevant lag period preceding inter-
ention, the infarcted wall would be expected to have
Figure 2 Representative Histological Sections
Representative histological sections of the infarction control (A) and PEUU patche
Black arrows indicate the top of the PEUU implanted area, which appears dark vio
staining appear in C to F where C and D are infarcted control and E and F are PEU
staining appears blue. Increased smooth muscle actin is apparent in the PEUU parogressed through the necrotic phase and into the fibrotic ihase (2). A particularly encouraging finding was the effect
hat patch placement had on tissue remodeling at the
tructural level with the development of smooth muscle
undles in the tissue below the patch and the alteration in
yocardial wall thickness and compliance.
The PEUU material was chosen for its elastic mechanical
roperties, processability, expected biocompatibility, and
iodegradability (14,15). It was shown that after 8 weeks of
mplantation, most of the material had degraded in vivo. By
tilizing an elastic, degradable patch material, it was postu-
ated that temporary alteration of the mechanical environ-
ent would provide benefit, and that by degrading, the
EUU material would avoid potential complications asso-
iated with a nondegradable material such as providing a
hronic nidus for infection and calcification. Also, our
xperience with the regional application was a 0% mortality
ate with minimal adhesion formation evident at the time of
xplant as well as no evidence of infection. Should this
pproach be scalable to humans, one would expect that the
rocedure could be performed in a low-risk manner and the
echanical properties of the PEUU material also were
menable to rolling, folding, or other compression tech-
iques that might allow the patch to be placed minimally
nvasively.
Several possible mechanisms might explain the functional
enefits associated with the patch. First, mechanical rein-
orcement provided by the PEUU material would acutely
ct to prevent further LV dilatation, which subsequently
yocardial wall 8 weeks after implantation stained with hematoxylin and eosin.
igher magnification of hematoxylin and eosin staining and immunohistochemical
ched. -SMA staining appears green, CD31 staining appears red, and nuclear
group. Scale bars in A and B are 500 m. For C to F, scale bars are 200 m.d (B) m
let. H
U pat
tchedncreases LV wall tension (6). Second, increased wall
t
L
r
a
c
n
f
fi
(
i
e
s
b
r
f
t
w
a
m
t
H
a
c
p
v
g
t
f
p
m
b
m
g
w
t
2297JACC Vol. 49, No. 23, 2007 Fujimoto et al.
June 12, 2007:2292–300 Biodegradable Patch Improves Cardiac Remodelinghickness, even after the patch had degraded, might reduce
V wall stress versus untreated infarct control. Finally, the
egional myocardial compliance of patched myocardium
pproached that of normal myocardium and was signifi-
antly higher than infarction control, which stiffened. This
ear normal physiologic compliance might act to prevent
urther LV dilation and improve cardiac function. Our
ndings would appear to contradict the work of Pfeffer et al.
21) where it was reported that LV chamber compliance
ncreases (by pressure-volume relations) after infarction. How-
ver, Omens et al. (22) demonstrated that the regional LV
train P-E response after infarction may not be well predicted
y the overall LV chamber pressure-volume response. With
espect to the abundant contractile smooth muscle cell bundles
ound in the LV walls of patched animals, there is no evidence
hat they contributed to LV function, and further studies
ould be necessary to examine this potential effect.
In considering the role of the inflammatory response
Figure 3 Characterization of -SMA–Positive Cells
Smooth muscle myosin heavy chain isotype II (SMMHC-II) (A) immunohistochemic
ing mature contractile ability. Electron micrographs (B to D) of the muscle-like bun
cal of mature contractile phenotype smooth muscle cells. White arrow denotes ca
m, and for C and D are 100 nm. My  myofibril; N  nuclear.ssociated with PEUU biodegradation, this phenomenon aight act to enhance and extend the presence of granulation
issue in the infarct area, analogous to the effect pursued by
ayakawa et al. (23). The PEUU will degrade by hydrolysis
nd, when small enough particles are generated, be phago-
ytosed by macrophages at the implant site. We found
ronounced expression of bFGF and VEGF around the
essels and smooth muscle bundles in the PEUU patch
roup with significantly increased capillary density relative
o infarction control. These locally released angiogenic
actors, potentially released by local macrophages, might
ositively influence tissue remodeling. In addition to
aterial phagocytosis, the scraping procedure employed
efore patch placement might augment this local inflam-
atory response acutely. Further studies to define specific
rowth factor and cytokine release patterns would be
arranted.
Several limitations of the current report should be men-
ioned. First, the beneficial effects in terms of cardiac function
ning colocalized with alpha-smooth muscle actin (-SMA)–positive cells suggest-
eneath the polyester urethane urea patch exhibited ultrastructural features typi-
Black arrow indicates dense bodies. Scale bars for A are 20 m, for B are 2al stai
dles b
veole.nd LV remodeling were only observed in the 8-week period
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ubstantially degraded in this period, the sustainability of
he architectural and functional changes remains to be
xamined for longer periods of time. There might theoret-
cally be some optimal time point when the patch would
ave provided its beneficial effect and degradation would be
esired. To investigate this effect, the time course of patch
egradation could be altered by manipulating the polymer
hemistry while maintaining comparable mechanical prop-
Figure 4 bFGF and VEGF Immunohistochemical Staining
Immunohistochemical staining for basic fibroblast growth factor (bFGF) (A and B) a
urethane urea patch (A and C) and infarction control (B and D) groups. The left im
merges in alpha-smooth muscle actin (-SMA) staining. Growth factor staining is r
Figure 5 Echocardiographic Assessment
Echocardiographic assessment of the polyester urethane urea patch, infarction co
(A), and % fractional area change in (B). End-diastolic area and % fractional area
and infarction control groups (p  0.05) at each time point and did not significant
implantation (pre) within group. 4w  4 weeks after implantation; 8w  8 weeks arties (24). A second limitation of this report was employ-
ent of the rat model. Further exploration in a large animal
odel is needed where changes in the patched LV area and
he volume of impacted LV wall more closely approximate
he clinical setting. Finally, the origin of the smooth muscle
ell bundles that appear in the patched LV wall has not been
efined. Histological sections did not suggest an obvious
igration of this tissue from the healthy periphery of the
nfarct. One hypothesis is that this tissue is derived from
scular endothelial growth factor (VEGF) (C and D) in the polyester
f each set shows growth factor and nuclear staining, and the right image
MA staining is green, and nuclear staining is blue. Scale bars are 100 m.
nd normal control groups during the study period. End-diastolic area is shown in
in the normal control group were significantly different than those in the patch
during follow-up. *p  0.05 between groups; †p  0.05 versus just before
plantation.nd va
age o
ed, -Sntrol, a
change
ly vary
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June 12, 2007:2292–300 Biodegradable Patch Improves Cardiac Remodelingirculating cells rather than myocardial tissue. Employment
f a marrow ablation model where a chimera with fluores-
ently labeled reconstituted marrow is obtained would
ermit investigation of this theory (25).
onclusions
his report demonstrates that regional application of a
iodegradable and elastic polyurethane cardiac patch pre-
ented ventricular dilation and improved contractile func-
ion in a subacute rat infarction model. This approach might
rovide an attractive alternative to cellular cardiomyoplasty
r larger ventricular restraint devices for cardiac repair.
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